Skip to main content

Clinical Decision Support Systems (CDSS) Market Competitive Detailed Analysis and Growth Landscape to 2023

Clinical Decision Support Systems (CDSS) Market Trends By Component (Software), Product (Integrated CDSS), Model (Knowledge-Based CDSS) Delivery Mode (On-Premise CDSS), Mode of Advice (Active CDSS), Setting (Inpatient Setting), Type (Therapeutic CDSS), Application (Advanced CDSS), Growth Opportunity, Size, Demand, Technology and Regional Analysis – Global Forecast Till 2023.
The Clinical Decision Support Systems (CDSS) Market Size is set to witness a CAGR of 12%, which projects above-average growth for the global market.
The Clinical Decision Support Systems (CDSS) market is growing significantly over the past few years. The healthcare industry is witnessing a spurting growing due to the ever-increasing population that is prompting the need for effective treatment and care. The Players that leads the global CDSS market include
By Latest Product launches and investment in R&D are a few of the important strategies employed by the top players in the global market to facilitate growth.
Prominent players analyzed in the report include –
Allscripts
Carestream
Agfa-Gevaert Group
Elsevier B.V.
Athenahealth
Hearst Health
Cerner Corporation
Meditech
and Epic Systems Corporation
Wolters Kluwer Health
and among others.
Clinical Decision Support Systems (CDSS) Market Segmentation:
The global CDSS market is segmented into component, product, model, delivery mode, mode of advice, settings, type, application, and region. By component, the market is segmented into services, software, and hardware. Software accounted for the largest share of the market and valued USD 493.43 million in 2017 and is expected to maintain its lead while reaching an evaluation of USD 982.42 million by the end of 2023.
By product, the market is segmented into integrated CDSS and standalone CDSS. Integrated CDSS is found to have the majority share and is expected to grow at the fastest CAGR. Integration allows healthcare professionals to access solutions that are interconnected and share a common user interface and database, thus simplifying the process.
By model, the market is segmented into Knowledge-based CDSS, and Non-Knowledge-based CDSS. Knowledge-based CDSS accounts for the majority share of the market due to the high number of advantages this system has over non-knowledge based CDSS.
By delivery mode, the market is segmented into in-premise and cloud-based systems. With global technology moving toward adoption of cloud-based systems, the healthcare sector is no different. The low capital and operational costs incurred in the implementation of cloud-based systems is highly beneficial as compared to on-premise systems.
By mode of advice, the market is segmented into passive CDSS and active CDSS. The active CDSS segment accounts for the largest share of the market with approximately 75% of the total share.
By settings, the market is segmented into inpatient settings and ambulatory care settings. Inpatient settings account for over 70% of the total market due to the requirement of a large volume of patient data that is captured and analyzed by healthcare professionals.
By type, the market is segmented into therapeutic clinical decision support system and diagnostic clinical decision support system. Due to its ability to transform clinical health practices by providing a user interface with the best therapeutic practices, the therapeutic CDSS segment has the leading market position.
By application, the market is segmented into conventional clinical support systems and advanced clinical decision support system. The advanced CDSS segment accounts for the largest segment with the highest CAGR of 12.34% during the assessment period. Users of CDSS has opting to upgrade conventional systems to include premium functions such as treatment planning protocol, population health management, patient record management, protocol validation, reasoning based models and health economics management too.
Contact:
Market Research Future, Pune – 411028
Maharashtra, India
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

  Immunoassay Analyzers Market  Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...
Post a Comment
Read more

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

  Laser Therapy Market  Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...
Post a Comment
Read more

Nonallergic Rhinitis Market Data, Technology Treatment and Diagnosis Management Overview

  Nonallergic Rhinitis Market  Share, Growth And Trends Analysis By Diagnosis (Physical Examination, Allergy Testing, And Imaging Test), By Treatment (Nasal Sprays, Nsaids), And By End User (Hospitals &, Clinics, Research Centers) - Global Forecast Till 2023 Market Highlights Nonallergic rhinitis, also known as vasomotor rhinitis is a medical condition that refers to a set of symptoms that resemble nasal allergies and hayfever (allergic rhinitis) occurring without a known cause. Some of the symptoms of non-allergic rhinitis include Postnasal drip, Runny nose, Sneezing, and Stuffy nose among others. Some patients with nonallergic rhinitis may even develop allergies and asthma eventually, hence treating the condition well in time becomes essential. Industry, Innovation & Related News November 08, 2018 – AstraZeneca Plc. (the UK), a multinational pharmaceutical and biopharmaceutical company announced the sale of its rights for asthma drug Alvesco (ciclesonide), nasal spra...
Post a Comment
Read more